# A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder

> **NCT00073203** · PHASE2 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 488 (—)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** R228060
- **DRUG:** Placebo and Paroxetine

## Key facts

- **NCT ID:** NCT00073203
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 488 (—)
- **Last updated:** 2009-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00073203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00073203, "A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00073203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*